Paradox of choice: Are multiple treatment options in renal cell carcinoma presenting opportunities or indecisiveness?
June 22, 2017 will be the first World Kidney Cancer Q&A Day, where international kidney cancer communities in collaboration with the... In DRG Blog/ June, 2017 Decision Resources Group’s Pick of the Most Interesting Novel Immune Checkpoint Agents Featured at AACR 2017
The AACR annual meeting starts tomorrow, where many interesting early-phase immune checkpoint targeted therapies that will be reported on. Here are... In DRG Blog/ March, 2017